Clinical trials
Phase 2 Coronary Disease trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2010 | 1 |
| 2012 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 2 |
| Novartis Pharmaceuticals | 2 |
| Sanofi | 2 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| Genentech, Inc. | 1 |
| Glycemic Index Laboratories, Inc | 1 |
| Schering-Plough | 1 |
| University of Manitoba | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Disease | 12 |
| Acute Coronary Syndrome | 1 |
| Atherosclerosis | 1 |
| Coronary Artery Disease | 1 |
| Dyslipidemias | 1 |
| Hypercholesterolemia | 1 |
| Hyperlipidemias | 1 |
| Myocardial Infarction | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.